Paulina Lange

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

John Koreth, Haesook T. Kim, Kyle T. Jones et al. · Blood · 2016 · 216 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)

Nadine Tung, Banu Arun, Michele R. Hacker et al. · Journal of Clinical Oncology · 2020 · 130 citations · Full text

Medicine, Oncology, Pharmacology +16

The addition of sirolimus to the graft‐versus‐host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trial

Philippe Armand, Haesook T. Kim, Marie-Michèle Sainvil et al. · British Journal of Haematology · 2016 · 57 citations · Full text

Medicine, Immunology, Pharmacotherapy +11

The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034)

Faina Nakhlis, Gabrielle M. Baker, Melissa Pilewskie et al. · Annals of Surgical Oncology · 2020 · 43 citations

Medicine, Oncology, Pathology +7

Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II results

John Koreth, Haesook T. Kim, Paulina Lange et al. · Haematologica · 2018 · 36 citations · Full text

Life Sciences, Hematology, Immunology +17